Projects per year
Abstract
Introduction: Preterm infants are at high risk for white matter injury and subsequent neurodevelopmental impairments. Mesenchymal stem/stromal cells (MSC) have anti-inflammatory/immunomodulatory actions and are of interest for neural repair in adults and newborns. This study examined the neuroprotective effects of allogeneic MSC, derived from preterm umbilical cord blood (UCB), in a preterm sheep model of white matter injury. Methods: Quad-lineage differentiation, clonogenicity and self-renewal ability of UCB-derived MSC were confirmed. Chronically instrumented fetal sheep (0.7 gestation) received either 25 min hypoxia-ischemia (HI) to induce preterm brain injury, or sham-HI. Ten million MSC, or saline, were administered iv to fetuses at 12 h after HI. Fetal brains were collected 10d after HI for histopathology and immunocytochemistry. Results: HI induced white matter injury, as indicated by a reduction in CNPase-positive myelin fiber density. HI also induced microglial activation (Iba-1) in the periventricular white matter and internal capsule (P <.05 vs control). MSC administration following HI preserved myelination (P <.05), modified microglial activation, and promoted macrophage migration (CD163) and cell proliferation (Ki-67) within cerebral white matter (P <.05). Cerebral CXCL10 concentration was increased following MSC administration (P <.05), which was likely associated with macrophage migration and cell proliferation within the preterm brain. Additionally, MSC administration reduced systemic pro-inflammatory cytokine TNFα at 3d post-HI (P <.05). Conclusions: UCB-derived MSC therapy preserved white matter brain structure following preterm HI, mediated by a suppression of microglial activation, promotion of macrophage migration and acceleration of self-repair within the preterm brain. UCB-derived MSC are neuroprotective, acting via peripheral and cerebral anti-inflammatory and immunomodulatory mechanisms.
Original language | English |
---|---|
Pages (from-to) | 120-131 |
Number of pages | 12 |
Journal | Experimental Neurology |
Volume | 308 |
DOIs | |
Publication status | Published - 1 Oct 2018 |
Keywords
- Cell transplantation
- Cytokines
- Mesenchymal stem cells
- Oligodendrocytes
- Stem cell expansion
- Umbilical cord blood
Projects
- 1 Finished
-
Cord blood stem cells for cerebral palsy
Miller, S. (Primary Chief Investigator (PCI)), Fahey, M. (Chief Investigator (CI)) & Jenkin, G. (Chief Investigator (CI))
National Health and Medical Research Council (NHMRC) (Australia)
1/01/15 → 31/12/17
Project: Research